271 related articles for article (PubMed ID: 36788534)
21. Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study.
Taponen S; Martikainen H; Järvelin MR; Laitinen J; Pouta A; Hartikainen AL; Sovio U; McCarthy MI; Franks S; Ruokonen A
J Clin Endocrinol Metab; 2003 Jan; 88(1):141-7. PubMed ID: 12519843
[TBL] [Abstract][Full Text] [Related]
22. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
23. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial.
Jedel E; Labrie F; Odén A; Holm G; Nilsson L; Janson PO; Lind AK; Ohlsson C; Stener-Victorin E
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E37-45. PubMed ID: 20943753
[TBL] [Abstract][Full Text] [Related]
24. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.
Azziz R; Ehrmann D; Legro RS; Whitcomb RW; Hanley R; Fereshetian AG; O'Keefe M; Ghazzi MN;
J Clin Endocrinol Metab; 2001 Apr; 86(4):1626-32. PubMed ID: 11297595
[TBL] [Abstract][Full Text] [Related]
25. Effect of phlebotomy versus oral contraceptives containing cyproterone acetate on the clinical and biochemical parameters in women with polycystic ovary syndrome: a randomized controlled trial.
Behboudi-Gandevani S; Abtahi H; Saadat N; Tohidi M; Ramezani Tehrani F
J Ovarian Res; 2019 Aug; 12(1):78. PubMed ID: 31470879
[TBL] [Abstract][Full Text] [Related]
26. The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial.
Sangouni AA; Pakravanfar F; Ghadiri-Anari A; Nadjarzadeh A; Fallahzadeh H; Hosseinzadeh M
Eur J Nutr; 2022 Apr; 61(3):1199-1207. PubMed ID: 34727201
[TBL] [Abstract][Full Text] [Related]
27. Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome.
Sabuncu T; Harma M; Harma M; Nazligul Y; Kilic F
Fertil Steril; 2003 Nov; 80(5):1199-204. PubMed ID: 14607575
[TBL] [Abstract][Full Text] [Related]
28. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Genazzani AR
Fertil Steril; 2009 Aug; 92(2):626-34. PubMed ID: 18706545
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS).
Artar G; Tas B; Turan G; Uckan HH
Gynecol Endocrinol; 2022 Dec; 38(12):1104-1108. PubMed ID: 36579834
[TBL] [Abstract][Full Text] [Related]
30. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
Shi Y; Gao X; Sun X; Zhang P; Chen Z
Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
[TBL] [Abstract][Full Text] [Related]
31. The effect of metformin on hirsutism in polycystic ovary syndrome.
Kelly CJ; Gordon D
Eur J Endocrinol; 2002 Aug; 147(2):217-21. PubMed ID: 12153743
[TBL] [Abstract][Full Text] [Related]
32. Effects of vitamin D on insulin resistance and fasting blood glucose in pregnant women with insufficient or deficient vitamin D: a randomized, placebo-controlled trial.
Mirzaei-Azandaryani Z; Mohammad-Alizadeh-Charandabi S; Shaseb E; Abbasalizadeh S; Mirghafourvand M
BMC Endocr Disord; 2022 Oct; 22(1):254. PubMed ID: 36266683
[TBL] [Abstract][Full Text] [Related]
33. Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study.
Mishra N; Verma R; Jadaun P
Cureus; 2022 Jan; 14(1):e21781. PubMed ID: 35251851
[TBL] [Abstract][Full Text] [Related]
34. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
35. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
36. The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.
Tabrizi FPF; Farhangi MA; Vaezi M; Hemmati S
Nutr J; 2020 Aug; 19(1):82. PubMed ID: 32782010
[TBL] [Abstract][Full Text] [Related]
37. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
[TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.
Romualdi D; De Cicco S; Busacca M; Gagliano D; Lanzone A; Guido M
J Endocrinol Invest; 2013 Sep; 36(8):636-41. PubMed ID: 24105072
[TBL] [Abstract][Full Text] [Related]
39. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
[TBL] [Abstract][Full Text] [Related]
40. In utero exposure to maternal stressful life events and risk of polycystic ovary syndrome in the offspring: The Raine Study.
Koch T; Doherty DA; Dickinson JE; Juul A; Hart R; Bräuner EV; Hickey M
Psychoneuroendocrinology; 2021 Mar; 125():105104. PubMed ID: 33352473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
